Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study

Fig. 1

Graphical representation of study design. † Metformin, α-glucosidase inhibitors, GLP-1 receptor agonists, meglitinides, sulfonylureas, dipeptidyl-peptidase 4 inhibitor, or insulin. ‡ Censoring at an earliest of the outcome of interest, death, or 365 days after discharge. Abbreviations: EXCL, exclusion criteria window; HF, heart failure; SGLT2i, sodium-glucose co-transporter 2 inhibitor

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840